...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Identification of DNA-binding proteins that interact with the 5 '-flanking region of the human D-amino acid oxidase gene by pull-down assay coupled with two-dimensional gel electrophoresis and mass spectrometry
【24h】

Identification of DNA-binding proteins that interact with the 5 '-flanking region of the human D-amino acid oxidase gene by pull-down assay coupled with two-dimensional gel electrophoresis and mass spectrometry

机译:通过与二维凝胶电泳和质谱法相结合的下拉测定与人D-氨基酸氧化酶基因的5'馏分区域相互作用的DNA结合蛋白质的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

D-Amino acid oxidase (DAO) is a flavoenzyme that metabolizes D-amino acids and is expected to be a promising therapeutic target of schizophrenia and glioblastoma. The study of DNA-binding proteins has yielded much information in the regulation of transcription and other biological processes. However, proteins interacting with DAO gene have not been elucidated. Our assessment of human DAO promoter activity using luciferase reporter system indicated the 5'-flanking region of this gene (-4289 bp from transcription initiation site) has a regulatory sequence for gene expression, which is regulated by multi-protein complexes interacting with this region. By using pull-down assay coupled with two-dimensional gel electrophoresis and mass spectrometry, we identified six proteins binding to the 5 '-flanking region of the human DAO gene (zinc finger C2HC domain-containing protein 1A; histidine-tRNA ligase, cytoplasmic; molybdenum cofactor biosynthesis protein; 60S ribosomal protein L37; calponin-1; calmodulin binding protein and heterogeneous nuclear ribonucleoprotein A2/B1). These preliminary results will contribute to the advance in the understanding of the potential factors associated with the regulatory mechanism of DAO expression. (C) 2015 Elsevier B.V. All rights reserved.
机译:D-氨基酸氧化酶(DAO)是一种代谢D-氨基酸的黄酮,并且预期是精神分裂症和胶质母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞母细胞瘤的疗法靶标。 DNA结合蛋白的研究在转录和其他生物过程的调节中产生了许多信息。然而,没有阐明与DAO基因相互作用的蛋白质。我们对使用荧光素酶报告系统的人DAO启动子活性的评估表明了该基因的5'-侧翼区域(来自转录起始位点的-4289bp)具有基因表达的调节序列,其由与该区域相互作用的多蛋白复合物调节。通过使用与二维凝胶电泳和质谱耦合的下拉测定,我们鉴定了六种蛋白质与人DAO基因的5'-Flanking区域结合(含锌C2HC畴内蛋白质1A;组细胞 - TRNA连接酶,细胞质;钼辅因子生物合成蛋白; 60S核糖体蛋白L37; Calponin-1;钙调蛋白结合蛋白和异质核核糖核蛋白A2 / B1)。这些初步结果将有助于了解与DAO表达的调节机制相关的潜在因素的进步。 (c)2015 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号